These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA. Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397 [Abstract] [Full Text] [Related]
26. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Williams LM, Rudensky AY. Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892 [Abstract] [Full Text] [Related]
30. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Loser K, Hansen W, Apelt J, Balkow S, Buer J, Beissert S. Gene Ther; 2005 Sep; 12(17):1294-304. PubMed ID: 15973443 [Abstract] [Full Text] [Related]
31. Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. Kim J, Lahl K, Hori S, Loddenkemper C, Chaudhry A, deRoos P, Rudensky A, Sparwasser T. J Immunol; 2009 Dec 15; 183(12):7631-4. PubMed ID: 19923467 [Abstract] [Full Text] [Related]
32. Deacetylase inhibition promotes the generation and function of regulatory T cells. Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM, Li B, Turka LA, Olson EN, Greene MI, Wells AD, Hancock WW. Nat Med; 2007 Nov 15; 13(11):1299-307. PubMed ID: 17922010 [Abstract] [Full Text] [Related]
33. IPEX and FOXP3: clinical and research perspectives. Wildin RS, Freitas A. J Autoimmun; 2005 Nov 15; 25 Suppl():56-62. PubMed ID: 16243487 [Abstract] [Full Text] [Related]
34. Forkhead box protein 3: essential immune regulatory role. Nik Tavakoli N, Hambly BD, Sullivan DR, Bao S. Int J Biochem Cell Biol; 2008 Nov 15; 40(11):2369-73. PubMed ID: 18037337 [Abstract] [Full Text] [Related]
35. Functional stability of Foxp3+ regulatory T cells. da Silva Martins M, Piccirillo CA. Trends Mol Med; 2012 Aug 15; 18(8):454-62. PubMed ID: 22771168 [Abstract] [Full Text] [Related]
36. Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Godfrey VL, Rouse BT, Wilkinson JE. Am J Pathol; 1994 Aug 15; 145(2):281-6. PubMed ID: 8053488 [Abstract] [Full Text] [Related]
37. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, Rudensky AY, Weaver CT. Nat Immunol; 2007 Sep 15; 8(9):931-41. PubMed ID: 17694059 [Abstract] [Full Text] [Related]
38. CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy. Ishimaru N, Yamada A, Nitta T, Arakaki R, Lipp M, Takahama Y, Hayashi Y. Am J Pathol; 2012 Jan 15; 180(1):199-208. PubMed ID: 22067914 [Abstract] [Full Text] [Related]
39. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. Chen Z, Herman AE, Matos M, Mathis D, Benoist C. J Exp Med; 2005 Nov 21; 202(10):1387-97. PubMed ID: 16301745 [Abstract] [Full Text] [Related]
40. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis. Yarkoni S, Sagiv Y, Kaminitz A, Farkas DL, Askenasy N. Eur J Immunol; 2009 Oct 21; 39(10):2850-64. PubMed ID: 19735074 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]